(BXLT) (BXLT) Stock Price, News & Analysis

Company Overview

Baxalta Incorporated (Baxalta) is a biopharmaceutical company with a portfolio of differentiated therapies that seek to address medical needs across various disease areas, including hemophilia, immunology and oncology. Baxalta's categories of products include Hemophilia products, such as Advate, Adynovate, Recombinate, Hemofil M, Immunate, Immunine, Rixubis and Prothromplex Total; Inhibitor Therapies products, including FEIBA and OBIZUR; Immunoglobulin Therapies products, which include GAMMAGARD LIQUID/KIOVIG, HYQVIA, GAMMAGARD S/D and SUBCUVIA; BioTherapeutics products, including FLEXBUMIN, BUMINATE, ARALAST NP, GLASSIA NP and CEPROTIN, and Oncology product, such as ONCASPAR. Baxalta Company develops, manufactures and markets a portfolio of treatments for hemophilia and other bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute medical conditions, as well as oncology treatments for acute lymphoblastic leukemia.

Key Stats

• Today's Range: $46.02 to $46.02
• 50-Day Range: N/A
• 52-Week Range: $29.83 to $46.52
• Volume: N/A
• Average Volume: 12.66 million shs
• Market Capitalization: N/A
• P/E Ratio: 15.49
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BXLT Stock Analysis - Frequently Asked Questions

How were (BXLT)'s earnings last quarter?

(BXLT) (NYSE:BXLT) issued its quarterly earnings data on Thursday, April, 28th. The biotechnology company reported $0.47 EPS for the quarter, topping analysts' consensus estimates of $0.46 by $0.01. The company's revenue was up 10.3% on a year-over-year basis.

What other stocks do shareholders of (BXLT) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that (BXLT) investors own include Baxter International (BAX), Hawkins (HWKN), AbbVie (ABBV), Bristol Myers Squibb (BMY), Allergan (AGN), Bank of America (BAC) and Vertex Pharmaceuticals (VRTX).

Company Calendar

• Last Earnings: 4/28/2016
• Today: 8/27/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NYSE:BXLT
• CIK: 1620546
• Web: www.baxalta.com
• Phone: +1-224-9402000
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 15.49
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A